Dr. Mark M. Keating

Shantan Reddy, MD, specializes in hematology oncology and is board-certified in internal medicine, hospice and palliative medicine, and medical oncology by the American Board of Internal Medicine. He is affiliated with UPMC Somerset. Dr. Reddy received his medical degree from the Universidad Tecnológica de Santiago and completed his residency at Easton Hospital, followed by fellowships at Tulane University School of Medicine and the University of Texas MD Anderson Cancer Center. Dr. Reddy is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Familial Colorectal Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, EGFR Positive Lung Cancer, and Vitrectomy.

Michal Krauze, MD, PhD, is a medical oncologist at UPMC Hillman Cancer Center. He has a special interest in breast cancer, colon cancer, gastrointestinal oncology, thoracic oncology, lung cancer, genitourinary oncology, prostate cancer, and malignant hematology. Dr. Krauze is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Lung Adenocarcinoma.

Kristopher Hansen, DO, specializes in hematology oncology and is board-certified in internal medicine and medical oncology by the American Board of Internal Medicine. He is affiliated with UPMC Altoona. Dr. Hansen completed his fellowship at the University of Kansas School of Medicine, residency at Wake Forest University School of Medicine and medical degree at Edward Via College of Osteopathic Medicine. Dr. Hansen is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Chronic Lymphocytic Leukemia (CLL), and Chronic B-Cell Leukemia (CBCL).